Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Hemostatic Gauze Identification and Inspection Testing: Materials, Standards, and Methods

Hemostatic gauze identification and inspection testing verifies the material composition, physical performance, sterility, and biological safety of hemostatic wound dressings used in surgical, trauma, and first-aid care. By combining spectroscopic identification, textile characterization, chemical analysis, and biocompatibility evaluation against ISO, ASTM, EN, and GB standards, accredited third-party laboratories help manufacturers, healthcare providers, and regulators confirm product authenticity and regulatory compliance. This guide explains the sample types, testing items, analytical methods, and practical applications involved in a comprehensive hemostatic gauze testing program.

Technical Overview

Hemostatic gauze is a medical textile device engineered to accelerate the arrest of bleeding at wound sites. Depending on the product category, hemostatic action is achieved either through the intrinsic clotting activity of specialized polymers, such as oxidized regenerated cellulose, chitosan, or calcium alginate, or through the absorptive and mechanical wound-contact properties of conventional cotton gauze. Because clinical performance depends directly on the true chemical identity and structural quality of the material, identification and inspection testing is a critical element of the quality system for these devices.

Identification testing serves several distinct purposes. It confirms that the finished gauze is manufactured from the declared raw material, screens for counterfeit or adulterated products, verifies declared functional attributes such as absorbability and degradation behavior, and provides the technical evidence required for regulatory registration and batch release. Testing is typically performed by accredited third-party laboratories in accordance with internationally recognized standards published by ISO, ASTM, EN, JIS, and GB standardization bodies.

Product Categories Commonly Tested

  • Absorbable oxidized regenerated cellulose (ORC) hemostatic gauze
  • Chitosan-based hemostatic gauze and dressings
  • Calcium alginate hemostatic gauze and ropes
  • Collagen- or gelatin-based absorbable hemostatic fabrics
  • Conventional absorbent cotton gauze pads, rolls, and swabs with hemostatic claims
  • Compound products combining gauze carriers with hemostatic agents

Testing Samples

Representative sampling is essential for meaningful results. Samples are normally drawn from finished sterile units in their primary packaging, and sufficient quantity should be submitted to cover destructive physical, chemical, microbiological, and biological test sequences.

Absorbable Oxidized Regenerated Cellulose Gauze

These samples are woven or knitted fabrics of oxidized cellulose supplied in sterile sheets or strips. Identification testing focuses on confirming the cellulose backbone, the degree of oxidation expressed as carboxyl content, and the characteristic degradation behavior in physiological conditions.

Chitosan- and Alginate-Based Gauze

For these polysaccharide materials, testing verifies polymer identity, degree of deacetylation for chitosan, and calcium ion content for alginate products, together with gel-forming and fluid uptake performance.

Conventional Absorbent Gauze

Cotton or cotton-polyester gauze samples are tested for fiber composition, fabric construction, absorbency, and freedom from prohibited finishing agents, fluorescent whitening agents, and excessive chemical residues.

Finished Product and Packaging Samples

Complete sterile units, including primary packaging and labeling, are submitted so that sterility, sterilant residues, and packaging integrity can be assessed in parallel with material identification.

Testing Items

A comprehensive inspection program for hemostatic gauze combines identification, physical performance, chemical safety, and biological evaluation. Typical testing items are organized below.

Identification and Composition Analysis

  • FTIR infrared spectroscopy identification against reference spectra
  • Chemical spot tests for cellulose, chitosan, and alginate functional groups
  • Fiber morphology examination by optical microscopy
  • Carboxyl content and degree of oxidation for oxidized regenerated cellulose
  • Degree of deacetylation for chitosan materials
  • Calcium content determination for alginate gauze
  • Blend ratio verification for cotton-polyester products

Physical and Performance Testing

  • Appearance, dimensions, and mass per unit area
  • Yarn count, thread density, and weave construction
  • Tensile strength and elongation
  • Sinking time and absorbency in aqueous fluid
  • Fluid holding capacity and retention under compression
  • In vitro hemostatic performance, including whole blood clotting time and clotting index
  • Degradation and absorption behavior for absorbable products

Chemical Safety Testing

  • pH of aqueous extract
  • Heavy metals and trace element residues
  • Fluorescent substances screening under UV light
  • Ether-soluble and water-soluble substances
  • Residual solvents, processing aids, and sterilant residues such as ethylene oxide and ethylene chlorohydrin
  • Acidity or alkalinity of extracted solutions

Microbiological and Biological Testing

  • Sterility testing using membrane filtration or direct inoculation methods
  • Bioburden determination prior to sterilization
  • Bacterial endotoxins where applicable
  • In vitro cytotoxicity per the ISO 10993-5 test method
  • Sensitization, irritation, and intracutaneous reactivity screening
  • Hemolysis testing consistent with ASTM F756 practice
  • Acute systemic toxicity where required by the risk assessment

Testing Methods

Methods are selected to produce defensible identification evidence and quantitative performance data, and are performed in laboratories accredited to recognized conformity assessment schemes.

Spectroscopic Identification

Fourier transform infrared spectroscopy is the primary identification technique. The spectrum of the sample is compared with certified reference spectra of the declared polymer. Oxidized regenerated cellulose is confirmed by characteristic carboxyl absorption bands, chitosan by amide and amine group bands, and alginate by carboxylate bands, allowing reliable differentiation from ordinary cellulose gauze and from synthetic imitations.

Chemical and Titrimetric Analysis

Quantitative confirmation is achieved through wet chemistry. Carboxyl content in oxidized cellulose is determined by ion-exchange titration, in which the sample is treated with calcium acetate and the released acetic acid is titrated. Chitosan deacetylation degree is assessed by potentiometric or colloid titration, and alginate calcium content by complexometric titration. Staining reactions and combustion residue tests provide supplementary fiber confirmation.

Textile and Physical Test Methods

Fabric construction is evaluated using standard textile test methodology for thread density, mass per unit area, and tensile properties. Absorbency is measured by recording the sinking time of a specimen placed on the surface of standard aqueous fluid, and fluid holding capacity is determined gravimetrically after saturation, with compression retention testing where clinically relevant.

Biological, Sterility, and Residue Methods

Sterility is verified by membrane filtration per ISO 11737-2 methodology. Cytotoxicity is evaluated by extract exposure to cultured mammalian cells per ISO 10993-5, and hemolysis by contact with anticoagulated rabbit or human blood following ASTM F756 practice. Ethylene oxide residuals are quantified by headspace gas chromatography per ISO 10993-7 requirements. Biological evaluation is planned as a risk-based subset of the full ISO 10993 series.

Hemostatic Efficacy Evaluation

Functional performance is assessed through in vitro clotting assays, including whole blood clotting time and clotting index determination, with recalcified plasma assays and viscoelastic coagulation measurements used as supporting methods to compare the test article against negative and positive controls.

Applications

Identification and inspection testing of hemostatic gauze supports stakeholders across the medical device lifecycle.

  • Regulatory registration and conformity assessment for market authorization of new hemostatic products
  • Incoming material verification and supplier qualification for manufacturers
  • In-process and batch release quality control for sterilized finished goods
  • Authenticity verification and screening of counterfeit or mislabeled gauze in distribution channels
  • Post-market surveillance, complaint investigation, and adverse event root cause analysis
  • Import and export compliance verification against destination market requirements
  • Tender and procurement technical evaluation by hospitals and government agencies

FAQ

What is hemostatic gauze identification testing?

It is a laboratory program that confirms the true chemical and textile identity of a hemostatic gauze product and evaluates whether its absorbency, sterility, chemical purity, and biological safety meet declared specifications and applicable standards.

Which standards are commonly referenced?

Frequently referenced frameworks include the ISO 10993 series for biological evaluation, ISO 11737 for sterility and bioburden, ISO 11137 for radiation sterilization validation support, ASTM F756 for hemolysis testing, GB/T 16886 and GB/T 14233 national test method standards, and relevant EN and JIS textile and medical device standards.

How is oxidized cellulose gauze distinguished from ordinary gauze?

FTIR spectroscopy reveals the diagnostic carboxyl absorption bands of oxidized regenerated cellulose, and titrimetric carboxyl content determination provides quantitative confirmation. Ordinary cellulose gauze lacks these oxidized functional groups and gives distinctly different analytical results.

How much sample is required for a full test sequence?

Typically twenty to forty sterile finished units are recommended, allowing destructive samples for identification, physical, chemical, sterility, and biological testing plus retention samples. Exact quantities depend on product dimensions and the agreed test scope.

How long does a complete evaluation take?

Identification and physical chemical testing is generally completed within one to two weeks, while sterility testing requires a fourteen-day incubation period and biological assays such as cytotoxicity may extend the overall timeline to three to five weeks depending on the test panel.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing